Can Chlorpromazine help treat COVID-19?
A new research paper published in the journal L'Encéphale in May 2020 reports on the planned ReCoVery Study, which will examine the possibility of repurposing the antipsychotic drug chlorpromazine for the treatment of COVID-19.
No hay comentarios:
Publicar un comentario